Pulmonary arterial hypertension trials recruiting in Florida

All Pulmonary arterial hypertension trials nationally

Cities in Florida

Recruiting trials in Florida

• A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)
  NCT07218029 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Jacksonville, Orlando, Tampa
• A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
  NCT07143448 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Florida: Tampa
• Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
  NCT06274801 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Florida: Gainesville, Jacksonville
• Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
  NCT02249923 · Phase: Not specified · Ages: 1 Day to 21 Years · Sex: All (male and female) · Florida: St. Petersburg
• Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
  NCT04278404 · Phase: Not specified · Ages: 0 Years to 20 Years · Sex: All (male and female) · Florida: Jacksonville
• Pulmonary Hypertension Association Registry
  NCT04071327 · Phase: Not specified · Ages: 0 Years and older · Sex: All (male and female) · Florida: Jacksonville